Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Delta Air Lines
DAL
$54.2B
| $3.58M | 0.14% |
92,509
+73,423
| +385% | +$2.77M |
|
77
Cognizant
CTSH
$27.9B
| $3.51M | 0.13% |
71,776
+61,167
| +577% | +$2.98M |
|
78
Brown-Forman Class B
BF.B
$13.1B
| $3.41M | 0.13% |
113,231
-36,563
| -24% | -$1.07M |
|
79
Tyson Foods
TSN
$20.6B
| $3.37M | 0.13% |
89,700
+84,400
| +1,592% | +$3.38M |
|
80
Trip.com Group
TCOM
$29B
| $3.33M | 0.13% |
+104,126
| New | +$2.81M |
|
|
QCOR
81
PUT
DELISTED
QUESTCOR PHARMA INC
QCOR
| $3.24M | 0.12% |
35,000
| – | – |
|
82
Kforce
KFRC
$1.05B
| $3.15M | 0.12% |
145,741
+130,053
| +829% | +$2.83M |
|
83
Coca-Cola
KO
$392B
| $3.09M | 0.12% |
72,900
-31,460
| -30% | -$1.28M |
|
84
Cemex
CX
$16B
| $3.04M | 0.12% |
+258,719
| New | +$2.94M |
|
85
lululemon athletica
LULU
$13.7B
| $3.04M | 0.12% |
75,000
+10,000
| +15% | +$456K |
|
86
PepsiCo
PEP
$196B
| $2.99M | 0.11% |
+33,500
| New | +$2.89M |
|
87
JPMorgan Chase
JPM
$935B
| $2.95M | 0.11% |
51,190
+13,855
| +37% | +$779K |
|
88
NetApp
NTAP
$37.7B
| $2.89M | 0.11% |
79,055
+33,367
| +73% | +$1.2M |
|
|
ATVI
89
DELISTED
Activision Blizzard
ATVI
| $2.77M | 0.11% |
+124,248
| New | +$2.55M |
|
|
CONE
90
DELISTED
CyrusOne Inc Common Stock
CONE
| $2.77M | 0.11% |
111,200
+42,950
| +63% | +$942K |
|
|
EXL
91
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $2.75M | 0.11% |
+206,376
| New | +$2.67M |
|
92
CALL
Herc Holdings
HRI
$5.41B
| $2.52M | 0.1% |
+30,000
| New | +$2.53M |
|
93
Dollar General
DG
$27.2B
| $2.48M | 0.1% |
43,328
-6,729
| -13% | -$385K |
|
94
T-Mobile US
TMUS
$196B
| $2.41M | 0.09% |
71,816
+56,830
| +379% | +$1.84M |
|
|
RAI
95
DELISTED
Reynolds American Inc
RAI
| $2.38M | 0.09% |
78,696
-105,198
| -57% | -$3.02M |
|
96
CME Group
CME
$98.9B
| $2.33M | 0.09% |
32,900
+1,100
| +3% | +$77.4K |
|
97
Marvell Technology
MRVL
$213B
| $2.24M | 0.09% |
156,124
+124,124
| +388% | +$1.91M |
|
98
Fastenal
FAST
$58.8B
| $2.23M | 0.09% |
180,000
-544,000
| -75% | -$6.73M |
|
99
Oracle
ORCL
$422B
| $2.17M | 0.08% |
53,490
+9,303
| +21% | +$383K |
|
100
Alcoa
AA
$13.7B
| $2.16M | 0.08% |
60,356
+10,921
| +22% | +$358K |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.